A new trading day began on Tuesday, with Genelux Corp (NASDAQ: GNLX) stock price down -12.60% from the previous day of trading, before settling in for the closing price of $3.89. GNLX’s price has ranged from $1.60 to $6.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -24.62% over the last five years. Meanwhile, its annual earnings per share averaged 24.31%. With a float of $30.04 million, this company’s outstanding shares have now reached $34.54 million.
The firm has a total of 23 workers. Let’s measure their productivity. In terms of profitability, gross margin is 55.64%, operating margin of -1966.64%, and the pretax margin is -1879.08%.
Genelux Corp (GNLX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Genelux Corp is 13.03%, while institutional ownership is 14.12%. The most recent insider transaction that took place on Dec 30 ’24, was worth 8,512. In this transaction Director of this company sold 3,460 shares at a rate of $2.46, taking the stock ownership to the 45,791 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director proposed sale 3,460 for $2.46, making the entire transaction worth $8,512.
Genelux Corp (GNLX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 24.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.19% during the next five years compared to -23.84% drop over the previous five years of trading.
Genelux Corp (NASDAQ: GNLX) Trading Performance Indicators
Here are Genelux Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.47. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11743.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Genelux Corp (GNLX)
Analysing the last 5-days average volume posted by the [Genelux Corp, GNLX], we can find that recorded value of 0.18 million was lower than the volume posted last year of 0.23 million. As of the previous 9 days, the stock’s Stochastic %D was 66.94%. Additionally, its Average True Range was 0.44.
During the past 100 days, Genelux Corp’s (GNLX) raw stochastic average was set at 33.82%, which indicates a significant increase from 27.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.09% in the past 14 days, which was higher than the 102.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.96, while its 200-day Moving Average is $2.80. Now, the first resistance to watch is $3.65. This is followed by the second major resistance level at $3.90. The third major resistance level sits at $4.21. If the price goes on to break the first support level at $3.09, it is likely to go to the next support level at $2.78. Should the price break the second support level, the third support level stands at $2.53.
Genelux Corp (NASDAQ: GNLX) Key Stats
With a market capitalization of 117.43 million, the company has a total of 34,538K Shares Outstanding. Currently, annual sales are 170 K while annual income is -28,300 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,580 K.
